The DOI matches its Crossref record; 142 of the 142 references it cites were found in a registry or an index.
Regulation of cancer cell metabolism
Abstract
Interest in the topic of tumour metabolism has waxed and waned over the past century of cancer research. The early observations of Warburg and his contemporaries established that there are fundamental differences in the central metabolic pathways operating in malignant tissue. However, the initial hypotheses that were based on these observations proved inadequate to explain tumorigenesis, and the oncogene revolution pushed tumour metabolism to the margins of cancer research. In recent years, interest has been renewed as it has become clear that many of the signalling pathways that are affected by genetic mutations and the tumour microenvironment have a profound effect on core metabolism, making this topic once again one of the most intense areas of research in cancer biology.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“One possible explanation for the observed difference between cSNVs and dbSNVs could be system-wide alterations in cancer cells, which are often characterized by increased replication stress, altered DNA repair mechanisms or changes in chromatin structure (85,86).”
From G-quadruplex-mediated genomic instability drives SNVs in cancer (2024) · cites this paper as [85]
In the citing paper
“Recent findings implicate TME in the induced metabolic rewiring in cancer cells (Cairns et al., 2011; Fiaschi and Chiarugi, 2012; Rattigan et al., 2012).”
From Tumor microenvironment derived exosomes pleiotropically modulate cancer cell metabolism (2016) · cites this paper as Cairns et al., 2011
In the citing paper
“Unlike normal cells, which derive most of their energy from mitochondrial oxidative phosphorylation, cancer cells rely on aerobic glycolysis as their primary energy resource. This process is recognized as the “Warburg effect”21–23.”
From RETRACTED ARTICLE: Fasting inhibits aerobic glycolysis and proliferation in colorectal cancer via the Fdft1-mediated AKT/mTOR/HIF1α pathway suppression (2020) · cites this paper as [22]
Citations
Cites
Understanding the Warburg Effect: The Metabolic Requirements of Cell Proliferation
Vander Heiden, M. G., Cantley, L. C., & Thompson, C. B. (2009) · Science · doi:10.1126/science.1160809 · Cited by 16,197
Warburg, O. (1956) · Science · doi:10.1126/science.123.3191.309 · Cited by 13,425
Mitochondrial Dysfunction and Oxidative Stress in Neurodegenerative Diseases
Lin, M. T., & Beal, M. F. (2006) · Nature · doi:10.1038/nature05292 · Cited by 6,455
An Integrated Genomic Analysis of Human Glioblastoma Multiforme
Parsons, D. W., Jones, S., Zhang, X., Lin, J. C.-H., Leary, R. J., Angenendt, P., Mankoo, P., Carter, H., Siu, I.-M., Gallia, G. L., et al. (2008) · Science · doi:10.1126/science.1164382 · Cited by 5,857
IDH1 and IDH2 Mutations in Gliomas
Yan, H., Parsons, D. W., Jin, G., McLendon, R., Rasheed, B. A., Yuan, W., Kos, I., Batinic-Haberle, I., Jones, S., Riggins, G. J., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0808710 · Cited by 5,847
Targeting cancer cells by ROS-mediated mechanisms: a radical therapeutic approach?
Trachootham, D., Alexandre, J., & Huang, P. (2009) · Nature Reviews Drug Discovery · doi:10.1038/nrd2803 · Cited by 5,452
Why Do Cancers Have High Aerobic Glycolysis?
Gatenby, R. A., & Gillies, R. J. (2004) · Nature reviews. Cancer · doi:10.1038/nrc1478 · Cited by 4,784
Cancer-associated IDH1 mutations produce 2-hydroxyglutarate
Dang, L., White, D. W., Gross, S., Bennett, B. D., Bittinger, M. A., Driggers, E. M., Fantin, V. R., Jang, H. G., Jin, S., Keenan, M. C., et al. (2009) · Nature · doi:10.1038/nature08617 · Cited by 4,154
Kim, J.-W., Tchernyshyov, I., Semenza, G. L., & Dang, C. V. (2006) · Cell Metabolism · doi:10.1016/j.cmet.2006.02.002 · Cited by 3,905
Stratton, M. R., Campbell, P. J., & Futreal, P. A. (2009) · Nature · doi:10.1038/nature07943 · Cited by 3,625
Flagged first, then by citations
Cited by
Sorted by citations
Items 201–300 of 1,016
Biology of glucose metabolization in cancer cells
Fadaka, A. O., Ajiboye, B. O., Ojo, O. A., Adewale, O. B., Olayide, I., & Emuowhochere, R. (2017) · Journal of Oncological Sciences · doi:10.1016/j.jons.2017.06.002 · Cited by 309
Tumor suppressor p53 and metabolism
Liu, J., Zhang, C., Hu, W., & Feng, Z. (2018) · Journal of Molecular Cell Biology · doi:10.1093/jmcb/mjy070 · Cited by 313
Biosystem‐Inspired Engineering of Nanozymes for Biomedical Applications
Zhang, L., Wang, H., & Qu, X. (2023) · Advanced Materials · doi:10.1002/adma.202211147 · Cited by 302
Molecular Mechanisms behind Free Radical Scavengers Function against Oxidative Stress
Ahmadinejad, F., Møller, S. G., Chaleshtori, M. H., Bidkhori, G., & Jami, M. (2017) · Antioxidants · doi:10.3390/antiox6030051 · Cited by 315
Exercise-dependent regulation of the tumour microenvironment
Koelwyn, G. J., Quail, D. F., Zhang, X., White, R. M., & Jones, L. W. (2017) · Nature reviews. Cancer · doi:10.1038/nrc.2017.78 · Cited by 307
Pro-oxidant activity of polyphenols and its implication on cancer chemoprevention and chemotherapy.
León-González, A., Auger, C., & Schini-Kerth, V. (2015) · Biochemical Pharmacology · doi:10.1016/j.bcp.2015.07.017 · Cited by 271
Lactate shuttles at a glance: from physiological paradigms to anti-cancer treatments
Draoui, N., & Féron, O. (2011) · Disease Models & Mechanisms · doi:10.1242/dmm.007724 · Cited by 307
Gluconeogenesis in Cancer: Function and Regulation of PEPCK, FBPase, and G6Pase
Wang, Z., & Dong, C. (2018) · Trends in cancer · doi:10.1016/j.trecan.2018.11.003 · Cited by 300
Signaling pathways in cancer metabolism: mechanisms and therapeutic targets
You, M., Xie, Z., Zhang, N., Zhang, Y., Xiao, D., Liu, S., Zhuang, W., Li, L., & Tao, Y. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01442-3 · Cited by 317
Tumor Microenvironment in Head and Neck Squamous Cell Carcinoma
Curry, J., Sprandio, J. D., Cognetti, D. M., Luginbuhl, A., Bar‐Ad, V., Pribitkin, E. A., & Tuluc, M. (2014) · Seminars in Oncology · doi:10.1053/j.seminoncol.2014.03.003 · Cited by 295
Agnihotri, S., & Zadeh, G. M. (2015) · Neuro-Oncology · doi:10.1093/neuonc/nov125 · Cited by 302
ROS homeostasis and metabolism: a critical liaison for cancer therapy
Kim, J., Kim, J., & Bae, J. (2016) · Experimental & Molecular Medicine · doi:10.1038/emm.2016.119 · Cited by 304
BRCA1 interacts with Nrf2 to regulate antioxidant signaling and cell survival
Gorrini, C., Baniasadi, P. S., Harris, I. S., Silvester, J., Inoue, S., Snow, B., Joshi, P. A., Wakeham, A., Molyneux, S. D., Martin, B., et al. (2013) · Journal of Experimental Medicine · doi:10.1084/jem.20121337 · Cited by 289
Self-citationMetabolic Plasticity as a Determinant of Tumor Growth and Metastasis
Lehuédé, C., Dupuy, F., Rabinovitch, R., Jones, R. G., & Siegel, P. M. (2016) · Cancer Research · doi:10.1158/0008-5472.can-16-0266 · Cited by 288
Regulation of reactive oxygen species in stem cells and cancer stem cells
Kobayashi, C. I., & Suda, T. (2011) · Journal of Cellular Physiology · doi:10.1002/jcp.22764 · Cited by 298
Lin, R., Elf, S., Shan, C., Kang, H.-B., Ji, Q., Zhou, L., Hitosugi, T., Zhang, L., Zhang, S., Seo, J. H., et al. (2015) · Nature Cell Biology · doi:10.1038/ncb3255 · Cited by 287
Up-down regulation of HIF-1α in cancer progression
Rashid, M., Zadeh, L. R., Baradaran, B., Molavi, O., Ghesmati, Z., Sabzichi, M., & Ramezani, F. (2021) · Gene · doi:10.1016/j.gene.2021.145796 · Cited by 302
ATF4-dependent induction of heme oxygenase 1 prevents anoikis and promotes metastasis
Dey, S., Sayers, C. M., Verginadis, I. I., Lehman, S. L., Cheng, Y., Cerniglia, G. J., Tuttle, S. W., Feldman, M. D., Zhang, P. J. L., Fuchs, S. Y., et al. (2015) · Journal of Clinical Investigation · doi:10.1172/jci78031 · Cited by 291
Hu, J. J., Wong, N.-K., Ye, S., Chen, X., Lu, M.-Y., Zhao, A. Q., Guo, Y., Chun‐Hang, A., Leung, A. Y. H., Shen, J., et al. (2015) · Journal of the American Chemical Society · doi:10.1021/jacs.5b01881 · Cited by 282
Reconstruction of genome-scale metabolic models for 126 human tissues using mCADRE
Wang, Y., Eddy, J. A., & Price, N. D. (2012) · BMC Systems Biology · doi:10.1186/1752-0509-6-153 · Cited by 285
The Influence of Metabolism on Drug Response in Cancer
Zaal, E. A., & Berkers, C. R. (2018) · Frontiers in Oncology · doi:10.3389/fonc.2018.00500 · Cited by 272
Saito, Y., Chapple, R. H., Lin, A. J., Kitano, A., & Nakada, D. (2015) · Cell stem cell · doi:10.1016/j.stem.2015.08.019 · Cited by 279
Lactate Dehydrogenases as Metabolic Links between Tumor and Stroma in the Tumor Microenvironment
Mishra, D., & Banerjee, D. (2019) · Cancers · doi:10.3390/cancers11060750 · Cited by 277
Shao, D., Zhai, P., Re, D. P. D., Sciarretta, S., Yabuta, N., Nojima, H., Lim, D., Pan, D., & Sadoshima, J. (2014) · Nature Communications · doi:10.1038/ncomms4315 · Cited by 280
Jia, D., Park, J. E., Jung, K., Levine, H., & Kaipparettu, B. A. (2018) · Cells · doi:10.3390/cells7030021 · Cited by 283
Magnetic resonance imaging of tumor glycolysis using hyperpolarized 13C-labeled glucose
Rodrigues, T. B., Serrão, E. M., Kennedy, B. W. C., Hu, D., Kettunen, M. I., & Brindle, K. M. (2013) · Nature Medicine · doi:10.1038/nm.3416 · Cited by 274
mTORC 1 and mTORC 2 as regulators of cell metabolism in immunity
Linke, M., Fritsch, S. D., Sukhbaatar, N., Hengstschläger, M., & Weichhart, T. (2017) · FEBS Letters · doi:10.1002/1873-3468.12711 · Cited by 283
Krisher, R. L., & Prather, R. S. (2012) · Molecular Reproduction and Development · doi:10.1002/mrd.22037 · Cited by 278
Hanigan, M. H. (2014) · Advances in cancer research · doi:10.1016/b978-0-12-420117-0.00003-7 · Cited by 271
Tumor suppressor p53 and its mutants in cancer metabolism
Liu, J., Zhang, C., Hu, W., & Feng, Z. (2013) · Cancer Letters · doi:10.1016/j.canlet.2013.12.025 · Cited by 276
Mechanisms for Modulating Anoikis Resistance in Cancer and the Relevance of Metabolic Reprogramming
Adeshakin, F. O., Adeshakin, A. O., Afolabi, L. O., Yan, D., Zhang, G., & Wan, X. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.626577 · Cited by 277
Principles of using Cold Atmospheric Plasma Stimulated Media for Cancer Treatment
Yan, D., Talbot, A., Nourmohammadi, N., Cheng, X., Canady, J., Sherman, J. H., & Keidar, M. (2015) · Scientific Reports · doi:10.1038/srep18339 · Cited by 276
Hypoxia-Driven Immune Escape in the Tumor Microenvironment
Vito, A., El-Sayes, N., & Mossman, K. L. (2020) · Cells · doi:10.3390/cells9040992 · Cited by 287
Liao, M., Yao, D., Wu, L., Luo, C., Wang, Z., Zhang, J., & Liu, B. (2023) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2023.12.003 · Cited by 299
The role of mitochondrial DNA mutations and free radicals in disease and ageing
Lagouge, M., & Larsson, N. (2013) · Journal of Internal Medicine · doi:10.1111/joim.12055 · Cited by 284
The Mitochondrial Chaperone TRAP1 Promotes Neoplastic Growth by Inhibiting Succinate Dehydrogenase
Sciacovelli, M., Guzzo, G., Morello, V., Frezza, C., Zheng, L., Nannini, N., Calabrese, F., Laudiero, G., Esposito, F., Landriscina, M., et al. (2013) · Cell Metabolism · doi:10.1016/j.cmet.2013.04.019 · Cited by 272
Fu, Y., Liu, S., Yin, S., Niu, W., Xiong, W., Tan, M., Li, G., & Zhou, M. (2017) · Oncotarget · doi:10.18632/oncotarget.18175 · Cited by 272
Pal, T., Mohiyuddin, S., & Packirisamy, G. (2018) · ACS Omega · doi:10.1021/acsomega.7b01323 · Cited by 263
Tedeschi, P. M., Markert, E. K., Gounder, M. K., Lin, H., Dvorzhinski, D., Dolfi, S. C., Chan, L. L.-Y., Qiu, J., DiPaola, R. S., Hirshfield, K. M., et al. (2013) · Cell Death and Disease · doi:10.1038/cddis.2013.393 · Cited by 265
Cunningham, J. T., Moreno, M. V., Lodi, A., Ronen, S. M., & Ruggero, D. (2014) · Cell · doi:10.1016/j.cell.2014.03.052 · Cited by 260
Fatty acid oxidation is required for the respiration and proliferation of malignant glioma cells
Lin, H., Patel, S., Affleck, V., Wilson, I., Turnbull, D. M., Joshi, A. R., Maxwell, R. J., & Stoll, E. A. (2016) · Neuro-Oncology · doi:10.1093/neuonc/now128 · Cited by 258
O-GlcNAcylation of G6PD promotes the pentose phosphate pathway and tumor growth
Rao, X., Duan, X., Mao, W., Li, X., Li, Z., Li, Q., Zheng, Z., Xu, H., Chen, M., Wang, P. G., et al. (2015) · Nature Communications · doi:10.1038/ncomms9468 · Cited by 267
Pyruvate Kinase Isoform Expression Alters Nucleotide Synthesis to Impact Cell Proliferation
Lunt, S. Y., Muralidhar, V., Hosios, A. M., Israelsen, W. J., Gui, D. Y., Newhouse, L., Ogrodzinski, M. P., Hecht, V. C., Xu, K., Acevedo, P. N. M., et al. (2014) · Molecular Cell · doi:10.1016/j.molcel.2014.10.027 · Cited by 263
Caveolin-1 in the regulation of cell metabolism: a cancer perspective
Nwosu, Z. C., Ebert, M., Dooley, S., & Meyer, C. (2016) · Molecular Cancer · doi:10.1186/s12943-016-0558-7 · Cited by 257
STAT1 and STAT3 in tumorigenesis
Avalle, L., Pensa, S., Regis, G., Novelli, F., & Poli, V. (2012) · JAK-STAT · doi:10.4161/jkst.20045 · Cited by 260
Prigione, A., Rohwer, N., Hoffmann, S., Mlody, B., Drews, K., Bukowiecki, R., Blümlein, K., Wanker, E. E., Ralser, M., Cramer, T., et al. (2013) · Stem Cells · doi:10.1002/stem.1552 · Cited by 256
Mitophagy in Cancer: A Tale of Adaptation
Vara‐Pérez, M., Felipe‐Abrio, B., & Agostinis, P. (2019) · Cells · doi:10.3390/cells8050493 · Cited by 264
Li, L., & Li, W. (2015) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2015.01.004 · Cited by 257
OXPHOS mutations and neurodegeneration
Koopman, W. J. H., Distelmaier, F., Smeitink, J. A. M., & Willems, P. H. G. M. (2012) · The EMBO Journal · doi:10.1038/emboj.2012.300 · Cited by 270
Peck, B., Schug, Z. T., Zhang, Q., Dankworth, B., Jones, D. T., Smethurst, E. A., Patel, R., Mason, S. M., Jiang, M., Saunders, R. E., et al. (2016) · Cancer & Metabolism · doi:10.1186/s40170-016-0146-8 · Cited by 248
Drug resistance in pancreatic cancer: Impact of altered energy metabolism
Grasso, C., Jansen, G., & Giovannetti, E. (2017) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2017.03.026 · Cited by 260
Metabolic regulation of macrophage phenotype and function
Saha, S., Shalova, I. N., & Biswas, S. K. (2017) · Immunological Reviews · doi:10.1111/imr.12603 · Cited by 260
Xu, D., Shao, F., Bian, X., Meng, Y., Liang, T., & Lu, Z. (2021) · Cell Metabolism · doi:10.1016/j.cmet.2020.12.015 · Cited by 257
The circadian clock in cancer development and therapy
Fu, L., & Kettner, N. M. (2013) · Progress in Molecular Biology and Translational Science · doi:10.1016/b978-0-12-396971-2.00009-9 · Cited by 251
Biomaterials tools to modulate the tumour microenvironment in immunotherapy
Chao, Y., & Liu, Z. (2023) · Nature Reviews Bioengineering · doi:10.1038/s44222-022-00004-6 · Cited by 262
Selenium: An Antioxidant with a Critical Role in Anti-Aging
Bjørklund, G., Shanaida, M., Lysiuk, R., Antonyak, H., Klishch, I. M., Shanaida, V., & Peana, M. (2022) · Molecules · doi:10.3390/molecules27196613 · Cited by 264
Classification of mitocans, anti-cancer drugs acting on mitochondria
Neužil, J., Dong, L., Rohlena, J., Truksa, J., & Ralph, S. J. (2012) · Mitochondrion · doi:10.1016/j.mito.2012.07.112 · Cited by 255
ATP citrate lyase: A central metabolic enzyme in cancer
Icard, P., Wu, Z., Fournel, L., Coquerel, A., Lincet, H., & Alifano, M. (2019) · Cancer Letters · doi:10.1016/j.canlet.2019.12.010 · Cited by 247
Chemical Design of Activatable Photoacoustic Probes for Precise Biomedical Applications
Liu, Y., Teng, L., Yin, B., Meng, H., Yin, X., Huan, S., Song, G., & Zhang, X. (2022) · Chemical Reviews · doi:10.1021/acs.chemrev.1c00875 · Cited by 250
Weng, M.-L., Chen, W.-K., Chen, X.-Y., Lu, H., Sun, Z.-R., Yu, Q., Sun, P.-F., Xu, Y.-J., Zhu, M.-M., Jiang, N., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-15795-8 · Cited by 242
RetractedDing, J., Li, T., Wang, X., Zhao, E., Choi, J.-H., Yang, L., Zha, Y., Dong, Z., Huang, S., Asara, J. M., et al. (2013) · Cell Metabolism · doi:10.1016/j.cmet.2013.11.004 · Cited by 246
Li, Z., Xu, L., Wu, S., Xue, M., & Chen, W. (2014) · Cancer Science · doi:10.1111/cas.12461 · Cited by 243
Metformin elicits anticancer effects through the sequential modulation of DICER and c-MYC
Blandino, G., Valerio, M., Cioce, M., Mori, F., Casadei, L., Pulito, C., Sacconi, A., Biagioni, F., Cortese, G., Galanti, S., et al. (2012) · Nature Communications · doi:10.1038/ncomms1859 · Cited by 240
Cancer metabolism: Key players in metabolic reprogramming
Soga, T. (2012) · Cancer Science · doi:10.1111/cas.12085 · Cited by 247
Metabolic rearrangements in primary liver cancers: cause and consequences
Satriano, L., Lewińska, M., Rodrigues, P. M., Bañales, J. M., & Andersen, J. B. (2019) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-019-0217-8 · Cited by 245
Targeting cancer stem cells to suppress acquired chemotherapy resistance
Vidal, S. J., Rodríguez-Bravo, V., Galsky, M. D., Cordon‐Cardo, C., & Domenech, J. M. D. (2013) · Oncogene · doi:10.1038/onc.2013.411 · Cited by 244
Targeting tumor cell metabolism with statins
Clendening, J. W., & Penn, L. Z. (2012) · Oncogene · doi:10.1038/onc.2012.6 · Cited by 247
Liu, L., Lu, Y., Martinez, J., Bi, Y., Lian, G., Wang, T., Milasta, S., Wang, J., Yang, M., Liu, G., et al. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1518000113 · Cited by 243
DNA Damage, Repair, and Cancer Metabolism
Turgeon, M., Perry, N. J. S., & Poulogiannis, G. (2018) · Frontiers in Oncology · doi:10.3389/fonc.2018.00015 · Cited by 249
Cheng, Y., Dai, J., Sun, C., Liu, R., Zhai, T., Lou, X., & Xia, F. (2018) · Angewandte Chemie International Edition · doi:10.1002/anie.201712803 · Cited by 242
Metabolic reprogramming in triple-negative breast cancer
Wang, Z., Jiang, Q., & Dong, C. (2020) · Cancer Biology and Medicine · doi:10.20892/j.issn.2095-3941.2019.0210 · Cited by 248
“Under normoxic conditions, HIF-1 α is hydroxylated by the proline hydroxylase domain (PHD2; also known as EglN1) in an oxygen-and α -ketoglutarate ( α -KG)- dependent manner, which results in its ubiquitination and subsequent degradation 15 .”
BackgroundLucarelli, G. T., Galleggiante, V., Rutigliano, M., Sanguedolce, F., Cagiano, S., Bufo, P., Lastilla, G., Maiorano, E., Ribatti, D., Giglio, A., et al. (2015) · Oncotarget · doi:10.18632/oncotarget.3823 · Cited by 243
Formentini, L., Sánchez‐Aragó, M., Sánchez-Cenizo, L., & Cuezva, J. M. (2012) · Molecular Cell · doi:10.1016/j.molcel.2012.01.008 · Cited by 240
Dysregulated lipid metabolism in cancer
Zhang, F. (2012) · World Journal of Biological Chemistry · doi:10.4331/wjbc.v3.i8.167 · Cited by 241
Heterogeneity in Cancer Metabolism: New Concepts in an Old Field
Gentric, G., Mieulet, V., & Mechta‐Grigoriou, F. (2016) · Antioxidants and Redox Signaling · doi:10.1089/ars.2016.6750 · Cited by 248
TGFβ-induced metabolic reprogramming during epithelial-to-mesenchymal transition in cancer
Hua, W., ten Dijke, P., Kostidis, S., Giera, M. A., & Hornsveld, M. (2019) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-019-03398-6 · Cited by 245
The emerging role of miR‐375 in cancer
Yan, J., Lin, J., & He, X. (2013) · International Journal of Cancer · doi:10.1002/ijc.28563 · Cited by 246
Spectrum of somatic mitochondrial mutations in five cancers
Larman, T., DePalma, S. R., Hadjipanayis, A. G., Protopopov, A. I., Zhang, J., Gabriel, S., Chin, L., Seidman, C. E., Kucherlapati, R., & Seidman, J. G. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1211502109 · Cited by 240
Pyruvate Kinase M2: Multiple Faces for Conferring Benefits on Cancer Cells
Tamada, M., Suematsu, M., & Saya, H. (2012) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-12-0859 · Cited by 238
Glutamine Metabolism in Cancer
Li, T., & Le, A. (2018) · Advances in experimental medicine and biology · doi:10.1007/978-3-319-77736-8_2 · Cited by 242
Seo, J., Jeong, D., Park, J., Lee, K., Fukuda, J., & Chun, Y. (2020) · Communications Biology · doi:10.1038/s42003-020-01367-5 · Cited by 237
Sayin, V. I., LeBoeuf, S. E., Singh, S. X., Davidson, S. M., Biancur, D., Guzelhan, B. S., Alvarez, S. W., Wu, W. L., Karakousi, T. R., Zavitsanou, A. M., et al. (2017) · eLife · doi:10.7554/elife.28083 · Cited by 231
Gaude, E., Schmidt, C., Gammage, P. A., Dugourd, A. J. F., Blacker, T. S., Peak‐Chew, S., Sáez-Rodríguez, J., O'Neill, J. S., Szabadkai, G., Minczuk, M. A., et al. (2018) · Molecular Cell · doi:10.1016/j.molcel.2018.01.034 · Cited by 235
TAp73 enhances the pentose phosphate pathway and supports cell proliferation
Du, W., Jiang, P., Mancuso, A., Stonestrom, A. J., Brewer, M. D., Minn, A. J., Mak, T. W., Wu, M., & Yang, X. (2013) · Nature Cell Biology · doi:10.1038/ncb2789 · Cited by 238
Self-citationMYC inhibition induces metabolic changes leading to accumulation of lipid droplets in tumor cells
Zirath, H., Frenzel, A., Oliynyk, G., Segerström, L., Westermark, U., Larsson, K., Persson, M. M., Hultenby, K. R., Lehtiö, J., Einvik, C., et al. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1222404110 · Cited by 229
Glucose & oxygen exhausting liposomes for combined cancer starvation and hypoxia-activated therapy
Zhang, R., Feng, L., Dong, Z., Wang, L., Liang, C., Chen, J., Ma, Q., Zhang, R., Chen, Q., Wang, Y., et al. (2018) · Biomaterials · doi:10.1016/j.biomaterials.2018.02.004 · Cited by 235
SOD1, more than just an antioxidant
Eleuthério, E. C. A., Magalhães, R. S. S., Brasil, A. D. A., Neto, J. R. M., & Paranhos, L. H. (2020) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2020.108701 · Cited by 252
Iansante, V., Choy, P. M., Fung, S. W., Liu, Y., Chai, J.-G., Dyson, J., Río, A. D., D’Santos, C. S., Williams, R. L., Chokshi, S., et al. (2015) · Nature Communications · doi:10.1038/ncomms8882 · Cited by 245
Moro‐García, M. A., Mayo, J. C., Sainz, R. M., & Alonso‐Arias, R. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.00339 · Cited by 241
Zhao, L., Ji, G., Le, X., Wang, C., Xu, L., Feng, M., Zhang, Y., Yang, H., Xuan, Y., Yang, Y., et al. (2017) · Cancer Research · doi:10.1158/0008-5472.can-16-1615 · Cited by 232
Chu, Z., Yang, J., Zheng, W., Sun, J., Wang, W., & Qian, H. (2023) · Coordination Chemistry Reviews · doi:10.1016/j.ccr.2023.215049 · Cited by 235
The Warburg effect: Evolving interpretations of an established concept
Chen, X., Qian, Y., & Wu, S. (2014) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2014.08.027 · Cited by 234
Cancer Metabolism: Current Understanding and Therapies
Counihan, J. L., Grossman, E. A., & Nomura, D. K. (2018) · Chemical Reviews · doi:10.1021/acs.chemrev.7b00775 · Cited by 236
Chen, W., Wang, Y., Zhao, A., Li, X., Xie, G., Su, M., Zhao, L., Liu, J., Qu, C., Wei, R., et al. (2016) · Cancer Cell · doi:10.1016/j.ccell.2016.09.006 · Cited by 233
Metabolic Reprogramming in Breast Cancer and Its Therapeutic Implications
Gandhi, N. S., & Das, G. M. (2019) · Cells · doi:10.3390/cells8020089 · Cited by 237
Oestrogen-related receptors in breast cancer: control of cellular metabolism and beyond
Deblois, G., & Giguère, V. (2012) · Nature reviews. Cancer · doi:10.1038/nrc3396 · Cited by 230
Kon, S., Ishibashi, K., Katoh, H., Kitamoto, S., Shirai, T., Tanaka, S., Kajita, M., Ishikawa, S., Yamauchi, H., Yako, Y., et al. (2017) · Nature Cell Biology · doi:10.1038/ncb3509 · Cited by 226
Krstić, J., Trivanović, D. I., Mojsilović, S. B., & Santibanez, J. F. (2015) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2015/654594 · Cited by 228
Ricciardi, M. R., Mirabilii, S., Allegretti, M., Licchetta, R., Calarco, A., Torrisi, M. R., Foà, R., Nicolai, R., Peluso, G., & Tafuri, A. (2015) · Blood · doi:10.1182/blood-2014-12-617498 · Cited by 234
Regulation of Tumor Progression by Programmed Necrosis
Lee, S. Y., Ju, M. K., Jeon, H. M., Jeong, E. K., Lee, Y. J., Kim, C. H., Park, H. G., Han, S. I., & Kang, H. S. (2018) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2018/3537471 · Cited by 238
Metadata
- Authors
- Cairns, R. A., Harris, I. S., & Mak, T. W.
- Corresponding author
- Mak, Tak W.
- Venue
- Nature Reviews Cancer
- Published
- 2011-01-24
- Volume
- 11
- Issue
- 2
- Pages
- 85-95
- ISSN
- 1474-175X (ISSN-L)
- 1474-1768
- OpenAlex
- W2028897202
- Semantic Scholar
- 9d36b5b10983f1aa90a9d9d5a7bcffe671b38257
- Cited by
- 4,744
- References
- 142
- Citations by year
- 2026: 95 · 2025: 192 · 2024: 234 · 2023: 276 · 2022: 293 · 2021: 418 · 2020: 423 · 2019: 386 · 2018: 386 · 2017: 414 · 2016: 399 · 2015: 387 · 2014: 318 · 2013: 251 · 2012: 192
- FWCI
- 19.59
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Nature reviews. Cancer (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Hypoxia, and Metabolism
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Cancer and biochemical research
- Keywords
- cancer metabolism, Warburg effect, redox homeostasis, tumor microenvironment, carcinogenesis, central metabolic pathways
- MeSH terms
- Cell Transformation, Neoplastic, Humans, Neoplasms, Oxidation-Reduction, Transcription Factors, Signal Transduction, Gene Expression Regulation, Neoplastic, Intracellular Signaling Peptides and Proteins, Gene Regulatory Networks
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review